Cargando…
PD-L1 regulation by SDH5 via β-catenin/ZEB1 signaling
Programmed death-ligand 1 (PD-L1) is a crucial target for lung cancer immunotherapy. In lung cancer patients with high PD-L1 expression, blocking or reducing its expression can inhibit tumor growth. PD-L1 is regulated by signaling pathways, transcription factors and epigenetic factors, such as the G...
Autores principales: | Tuo, Zhan, Zong, Yan, Li, Jie, Xiao, Guangqin, Zhang, Furong, Li, Guiling, Wang, Sihua, Lv, Yi, Xia, Jiahong, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844322/ https://www.ncbi.nlm.nih.gov/pubmed/31741753 http://dx.doi.org/10.1080/2162402X.2019.1655361 |
Ejemplares similares
-
SDH5 Depletion Enhances Radiosensitivity by Regulating p53: A New Method for Noninvasive Prediction of Radiotherapy Response
por: Zong, Yan, et al.
Publicado: (2019) -
Role of β-catenin in PD-L1 expression of nasopharyngeal carcinoma
por: Wang, Haihua, et al.
Publicado: (2023) -
β-Catenin regulates tumor-derived PD-L1
por: Han, Chuanhui, et al.
Publicado: (2020) -
Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis
por: Han, Jihua, et al.
Publicado: (2017) -
Prognostic Role of Epithelial-Mesenchymal Transition Markers “E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63” in Bladder Carcinoma
por: Moussa, Rabab Ahmed, et al.
Publicado: (2019)